Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; and TearCare System, a wearable eyelid technology for the treatment of dry eye disease (DED) for ophthalmologists and optometrists. It offers its products through sales representatives and distributors to hospitals, medical centers, and eyecare professionals in the United States. The company was incorporated in 2010 and is headquartered in Menlo Park, California.[ Read More ]
The intrinsic value of one SGHT stock under the base case scenario is HIDDEN Compared to the current market price of 3.8 USD, Sight Sciences, Inc. is HIDDEN
Current Assets | 163 M |
Cash & Short-Term Investments | 138 M |
Receivables | 14.3 M |
Other Current Assets | 10.5 M |
Non-Current Assets | 3.78 M |
Long-Term Investments | 0 |
PP&E | 3.1 M |
Other Non-Current Assets | 682 K |
Current Liabilities | 12.3 M |
Accounts Payable | 1.73 M |
Short-Term Debt | 2.79 M |
Other Current Liabilities | 7.73 M |
Non-Current Liabilities | 34.2 M |
Long-Term Debt | 32.6 M |
Other Non-Current Liabilities | 1.56 M |
Revenue | 81.1 M |
Cost Of Revenue | 11.9 M |
Gross Profit | 69.2 M |
Operating Expenses | 126 M |
Operating Income | -57.3 M |
Other Expenses | -1.73 M |
Net Income | -55.5 M |
Net Income | -55.5 M |
Depreciation & Amortization | 614 K |
Capital Expenditures | -791 K |
Stock-Based Compensation | 14.6 M |
Change in Working Capital | -9.13 M |
Others | -4.45 M |
Free Cash Flow | -48 M |
Date | Value | Insider | Amount | Avg Price |
---|---|---|---|---|
4 weeks ago
Oct 18, 2024
|
Sell 122 K USD
|
Link Matthew
Chief Commercial Officer |
- 20487
|
5.977 USD |
3 weeks ago
Oct 21, 2024
|
Sell 122 K USD
|
Link Matthew
Chief Commercial Officer |
- 21831
|
5.609 USD |
1 month ago
Oct 16, 2024
|
Sell 122 K USD
|
Link Matthew
Chief Commercial Officer |
- 20734
|
5.905 USD |
1 month ago
Oct 17, 2024
|
Sell 122 K USD
|
Link Matthew
Chief Commercial Officer |
- 20970
|
5.839 USD |
1 month ago
Oct 02, 2024
|
Sell 76.2 K USD
|
Badawi Paul
President and CEO |
- 12727
|
5.986 USD |
1 month ago
Oct 01, 2024
|
Sell 29.7 K USD
|
HAYDEN JEREMY B.
Chief Legal Officer |
- 4878
|
6.08 USD |
1 month ago
Oct 02, 2024
|
Sell 19 K USD
|
Badawi David
Chief Technology Officer |
- 3167
|
5.986 USD |
1 month ago
Oct 01, 2024
|
Sell 61.6 K USD
|
Bauerlein Alison
Chief Financial Officer |
- 10130
|
6.08 USD |
1 month ago
Oct 01, 2024
|
Sell 20.7 K USD
|
Park Sam Boong
Chief Operating Officer |
- 3403
|
6.08 USD |
4 months ago
Jul 02, 2024
|
Sell 31.4 K USD
|
HAYDEN JEREMY B.
Chief Legal Officer |
- 5055
|
6.212 USD |
4 months ago
Jul 01, 2024
|
Sell 20.1 K USD
|
Badawi David
Chief Technology Officer |
- 3128
|
6.417 USD |
4 months ago
Jul 01, 2024
|
Sell 80.7 K USD
|
Badawi Paul
President and CEO |
- 12569
|
6.417 USD |
4 months ago
Jul 02, 2024
|
Sell 21.9 K USD
|
Park Sam Boong
Chief Operating Officer |
- 3525
|
6.212 USD |
4 months ago
Jul 02, 2024
|
Sell 65.2 K USD
|
Bauerlein Alison
Chief Financial Officer |
- 10497
|
6.212 USD |
6 months ago
May 17, 2024
|
Sell 70.9 K USD
|
Bauerlein Alison
Chief Financial Officer |
- 13066
|
5.424 USD |
7 months ago
Apr 03, 2024
|
Sell 24.9 K USD
|
HAYDEN JEREMY B.
Chief Legal Officer |
- 4893
|
5.079 USD |
7 months ago
Apr 03, 2024
|
Sell 63.8 K USD
|
Badawi Paul
President and CEO |
- 12571
|
5.079 USD |
7 months ago
Apr 03, 2024
|
Sell 15.9 K USD
|
Badawi David
Chief Technology Officer |
- 3128
|
5.079 USD |
7 months ago
Apr 03, 2024
|
Sell 17.3 K USD
|
Park Sam Boong
Chief Operating Officer |
- 3414
|
5.079 USD |
7 months ago
Apr 03, 2024
|
Sell 51.4 K USD
|
Bauerlein Alison
Chief Financial Officer |
- 10123
|
5.079 USD |
10 months ago
Jan 17, 2024
|
Sell 82.2 K USD
|
Badawi Paul
President and CEO |
- 15917
|
5.164 USD |
10 months ago
Jan 17, 2024
|
Sell 17.6 K USD
|
Badawi David
Chief Technology Officer |
- 3414
|
5.164 USD |
10 months ago
Jan 17, 2024
|
Sell 23.4 K USD
|
HAYDEN JEREMY B.
Chief Legal Officer |
- 4538
|
5.164 USD |
10 months ago
Jan 17, 2024
|
Sell 28.1 K USD
|
Park Sam Boong
Chief Operating Officer |
- 5443
|
5.164 USD |
10 months ago
Dec 27, 2023
|
Sell 16.7 M USD
|
D1 Capital Partners L.P.
10 percent owner |
- 2852036
|
5.86 USD |
11 months ago
Nov 30, 2023
|
Bought 487 K USD
|
Encrantz Staffan
director, 10 percent owner: |
+ 140777
|
3.4568 USD |
11 months ago
Nov 29, 2023
|
Bought 11.3 K USD
|
Encrantz Staffan
director, 10 percent owner: |
+ 3223
|
3.5 USD |
11 months ago
Nov 28, 2023
|
Bought 877 K USD
|
Encrantz Staffan
director, 10 percent owner: |
+ 253669
|
3.4578 USD |
11 months ago
Nov 27, 2023
|
Bought 816 K USD
|
Encrantz Staffan
director, 10 percent owner: |
+ 246331
|
3.3124 USD |
11 months ago
Nov 24, 2023
|
Bought 67.4 K USD
|
Encrantz Staffan
director, 10 percent owner: |
+ 21855
|
3.0852 USD |
11 months ago
Nov 22, 2023
|
Bought 103 K USD
|
Encrantz Staffan
director, 10 percent owner: |
+ 41085
|
2.4999 USD |
11 months ago
Nov 21, 2023
|
Bought 170 K USD
|
Encrantz Staffan
director, 10 percent owner: |
+ 68477
|
2.4758 USD |
11 months ago
Nov 20, 2023
|
Bought 178 K USD
|
Encrantz Staffan
director, 10 percent owner: |
+ 79234
|
2.2489 USD |
1 year ago
Nov 17, 2023
|
Bought 277 K USD
|
Encrantz Staffan
director, 10 percent owner: |
+ 126664
|
2.1892 USD |
1 year ago
Nov 16, 2023
|
Bought 678 USD
|
Encrantz Staffan
director, 10 percent owner: |
+ 339
|
2 USD |
1 year ago
Nov 14, 2023
|
Bought 6.91 K USD
|
Encrantz Staffan
director, 10 percent owner: |
+ 3462
|
1.997 USD |
2 years ago
May 13, 2022
|
Bought 2.46 M USD
|
Encrantz Staffan
director: |
+ 300000
|
8.2 USD |
2 years ago
May 13, 2022
|
Bought 41.4 K USD
|
Selnick Jesse
Chief Financial Officer |
+ 5000
|
8.28 USD |
2 years ago
Dec 01, 2021
|
Bought 1.44 M USD
|
Encrantz Staffan
Director |
+ 62959
|
22.92 USD |
2 years ago
Dec 01, 2021
|
Bought 2.77 M USD
|
Encrantz Staffan
Director |
+ 123931
|
22.36 USD |
2 years ago
Dec 01, 2021
|
Bought 594 K USD
|
Encrantz Staffan
Director |
+ 27716
|
21.43 USD |
2 years ago
Nov 30, 2021
|
Bought 1.19 M USD
|
Encrantz Staffan
Director |
+ 56836
|
20.96 USD |
2 years ago
Nov 30, 2021
|
Bought 1.94 M USD
|
Encrantz Staffan
Director |
+ 94969
|
20.4 USD |
2 years ago
Nov 30, 2021
|
Bought 1.4 M USD
|
Encrantz Staffan
Director |
+ 72135
|
19.44 USD |
2 years ago
Nov 29, 2021
|
Bought 41.9 K USD
|
Encrantz Staffan
Director |
+ 2200
|
19.06 USD |
2 years ago
Nov 29, 2021
|
Bought 1.59 M USD
|
Encrantz Staffan
Director |
+ 84254
|
18.84 USD |
2 years ago
Nov 23, 2021
|
Bought 184 K USD
|
Selnick Jesse
Chief Financial Officer |
+ 10000
|
18.4393 USD |
3 years ago
Oct 18, 2021
|
Bought 12.6 M USD
|
Encrantz Staffan
Director |
+ 527048
|
24 USD |
3 years ago
Jul 19, 2021
|
Bought 16.8 M USD
|
D1 Capital Partners L.P.
10 percent owner |
+ 700000
|
24 USD |